RNF141
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1944511389rs2191566GTrs21915664.00E-07METHOTREXATEPOLYGLUTAMIC ACID|ANTIMETABOLITES, ANTINEOPLASTIC|DOPA DECARBOXYLASE|MKL1 PROTEIN, HUMAN|IKAROS TRANSCRIPTION FACTOR|ARID5B PROTEIN, HUMAN|TRANSCRIPTION FACTORS|IKZF1 PROTEIN, HUMAN|ONCOGENE PROTEINS, FUSION|DNA-BINDING PROTEINSAcute lymphoblastic leukemia (childhood)HPOID:0006721DOID:9952|DOID:12603A,CintronGWASdb_drug
1110534866rs10770123CTrs107701239.31E-04Prostate cancer mortalityHPOID:0012125DOID:10283CUTR-3GWASdb_trait
1110540343rs1993819AGrs19938194.96E-04Prostate cancer mortalityHPOID:0012125DOID:10283AintronGWASdb_trait
1944511389rs2191566GTrs21915665.90E-04Multiple complex diseasesHPOID:0000118NAA,CintronGWASdb_trait
1944511389rs2191566GTrs21915664.00E-07Acute lymphoblastic leukemia (childhood)HPOID:0006721DOID:9952|DOID:12603A,CintronGWASdb_trait
1944511389rs2191566GTrs21915664.00E-07Nasopharyngeal carcinomaHPOID:0100630DOID:9261A,CintronGWASdb_trait
1944511589rs454904AGrs4549046.72E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000110315.6 RNF141 616641